Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

NanJing Pharmaceutical Co Ltd Announces FY 2012 Net Profit Outlook


Friday, 25 Jan 2013 07:00pm EST 

NanJing Pharmaceutical Co Ltd announced that it expects its net profit for fiscal year (FY) 2012 to be RMB 5 million to RMB 10 million, compared to the net profit of FY 2011 (RMB -182,616,734.08). The Company cited the improved operating efficiency and resource allocation efficiency as the main reason for the forecast. 

Company Quote

5.81
0.21 +3.75%
2:59am EDT